|
Status |
Public on Mar 28, 2012 |
Title |
MC0026_MCRxxx6_BM_CD138pos |
Sample type |
genomic |
|
|
Channel 1 |
Source name |
MC0026_MCRxxx6_BM_CD138pos DNA
|
Organism |
Homo sapiens |
Characteristics |
cell type: CD138 Positive Myeloma Cells sample order: 1 tc class: 4p16 cyto risk: high 17p13 deletion: monoallelic ploidy: non-hyperdiploid uams 70gene index: NA copy number abnormalities: 76 time since sample1 months: 9.87
|
Treatment protocol |
CD138 positive tumor cells were isolated from bone marrow aspirates using magnetic sorting, both Miltenyi and Stemcell Technologies
|
Growth protocol |
Bone marrow aspirates were attained from patients after they signed informed consent documentation
|
Extracted molecule |
genomic DNA |
Extraction protocol |
DNA was extracted from cell lysates stored in TRIzol or using Puregene isolations from Dry Cell Pellets
|
Label |
Cy5
|
Label protocol |
genomic DNA was digested with DNaseI for 12 minutes, digested DNA was labeled using the Invitrogen BioPrime Labeling kit, Test tumor samples were labeled with Cy5 and control DNA were labeled with Cy3
|
|
|
Channel 2 |
Source name |
Promega Female DNA
|
Organism |
Homo sapiens |
Characteristics |
reference: Promega Female DNA
|
Treatment protocol |
CD138 positive tumor cells were isolated from bone marrow aspirates using magnetic sorting, both Miltenyi and Stemcell Technologies
|
Growth protocol |
Bone marrow aspirates were attained from patients after they signed informed consent documentation
|
Extracted molecule |
genomic DNA |
Extraction protocol |
DNA was extracted from cell lysates stored in TRIzol or using Puregene isolations from Dry Cell Pellets
|
Label |
Cy3
|
Label protocol |
genomic DNA was digested with DNaseI for 12 minutes, digested DNA was labeled using the Invitrogen BioPrime Labeling kit, Test tumor samples were labeled with Cy5 and control DNA were labeled with Cy3
|
|
|
|
Hybridization protocol |
hybridizations were carried out as suggested in the Agilent Oligonucleotide Array-Based CGH for Genomic DNA Analysis Protocol Version 6.2 (October 2009)
|
Scan protocol |
scans were carried out as suggested in the Agilent Oligonucleotide Array-Based CGH for Genomic DNA Analysis Protocol Version 6.2 (October 2009) with both PMTs at 100%
|
Description |
Competitive Oligo CGH assay, MC0026_MCRxxx6_BM_CD138pos versus Promega Female DNA
|
Data processing |
Raw data was extracted from TIFF image files by Agilent Feature extraction using protocol CGH_107_Sep09 and grid 014693_D_F_20080627
|
|
|
Submission date |
Mar 26, 2012 |
Last update date |
Mar 28, 2012 |
Contact name |
Jonathan J Keats |
E-mail(s) |
[email protected]
|
Phone |
602-343-8690
|
Organization name |
Translational Genomics Research Institute (TGen)
|
Department |
Integrated Cancer Genomics
|
Lab |
Multiple Myeloma Research Lab - Keats Lab
|
Street address |
445 N. Fifth Street
|
City |
Phoenix |
State/province |
Arizona |
ZIP/Postal code |
85004 |
Country |
USA |
|
|
Platform ID |
GPL4091 |
Series (2) |
GSE36822 |
Clonal competition with alternating dominance in multiple myeloma [244kCGH] |
GSE36825 |
Clonal competition with alternating dominance in multiple myeloma |
|